Direct gene transfer into rat articular cartilage by in vivo electroporation

被引:34
作者
Grossin, L
Cournil-Henrionnet, C
Mir, LM
Liagre, B
Dumas, D
Etienne, S
Guingamp, C
Netter, P
Gillet, P
机构
[1] Univ Nancy 1, Fac Med, CNRS, UMR 7561, F-54505 Vandoeuvre Les Nancy, France
[2] Univ Nancy 1, Fac Med, CNRS, UMR Mecan & Ingn Cellulaire & Tissulaire 7563, F-54505 Vandoeuvre Les Nancy, France
[3] Inst Gustave Roussy, CNRS, UMR Vectorol & Transfert Genes 8121, F-94805 Villejuif, France
关键词
electropermeabilization; in vivo gene transfer; electro gene therapy; GFP; patellar cartilage;
D O I
10.1096/fj.02-0518com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To establish a system for efficient direct in vivo gene targeting into rat joint, we have evaluated a strategy of gene transfer by means of the delivery of external electric pulses (EP) to the knee after intra-articular injection of a reporter gene (GFP). Rats were killed at various times after the electro gene-therapy to analyze GFP gene expression by immunohistochemistry. GFP staining was detected in the superficial, middle, and deep zones of the patellar cartilage at days 2 and 9, and thereafter only in the deep zone (months 1 and 2). The average percentage of GFP-positive cells was estimated at 30% both one and 2 months after the gene transfer. Moreover, no pathologic change caused by the EP was detected in the cartilage. The level and stability of the long-term GFP expression found in this study demonstrate the feasibility of a treatment of joint disorders (inflammatory or degenerative, focal or diffuse) using electric gene transfer.
引用
收藏
页码:829 / 835
页数:7
相关论文
共 30 条
[1]   Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs [J].
Banga, AK ;
Prausnitz, MR .
TRENDS IN BIOTECHNOLOGY, 1998, 16 (10) :408-412
[2]   Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo [J].
Baragi, VM ;
Renkiewicz, RR ;
Qiu, LP ;
Brammer, D ;
Riley, JM ;
Sigler, RE ;
Frenkel, SR ;
Amin, A ;
Abramson, SB ;
Roessler, BJ .
OSTEOARTHRITIS AND CARTILAGE, 1997, 5 (04) :275-282
[3]  
Dumas D, 2000, BIORHEOLOGY, V37, P165
[4]  
Evans CH, 1999, ARTHRITIS RHEUM-US, V42, P1, DOI 10.1002/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO
[5]  
2-4
[6]   Tissue-engineered fabrication of an osteochondral composite graft using rat bone marrow-derived mesenchymal stem cells [J].
Gao, JZ ;
Dennis, JE ;
Solchaga, LA ;
Awadallah, AS ;
Goldberg, VM ;
Caplan, AI .
TISSUE ENGINEERING, 2001, 7 (04) :363-371
[7]  
Goater J, 2000, J RHEUMATOL, V27, P983
[8]   High-efficiency non-viral transfection of primary chondrocytes and perichondrial cells for ex-vivo gene therapy to repair articular cartilage defects [J].
Goomer, RS ;
Deftos, LJ ;
Terkeltaub, R ;
Maris, T ;
Lee, MC ;
Harwood, FL ;
Amiel, D .
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (03) :248-256
[9]   Mono-iodoacetate-induced experimental osteoarthritis - A dose-response study of loss of mobility, morphology, and biochemistry [J].
Guingamp, C ;
GegoutPottie, P ;
Philippe, L ;
Terlain, B ;
Netter, P ;
Gillet, P .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1670-1679
[10]   Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector [J].
Hong, K ;
Sherley, J ;
Lauffenburger, DA .
BIOMOLECULAR ENGINEERING, 2001, 18 (04) :185-192